Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Radzio, Jessica ^a   Aung, Wutyi ^a   Holder, Angela ^a   Martin, Amy ^a   Sweeney, Elizabeth ^a   Mitchell, James ^a   Bachman, Shanon ^a   Pau, Chou Pong ^a   Heneine, Walid ^a   García Lerma, J Gerardo ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; PLACEBO; TENOFOVIR; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MACACA; MENSTRUAL CYCLE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RECTUM; SEROLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE DRUG DOSE; VAGINAL SECRETION; VAGINITIS; VIREMIA; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; COITUS; DEOXYCYTIDINE; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; MACACA NEMESTRINA; ORGANOPHOSPHORUS COMPOUNDS; PROGESTERONE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VAGINA;

ANIMALIA; MACACA; MACACA NEMESTRINA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84870748389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050632     Document Type: Article

References (40)

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
2. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. (2012) Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. N Engl J Med July 11, 2012 (10.1056/NEJMoa1110711).
3. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. (2012) Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med 10.1056/NEJMoa1108524.
4. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. (2012) Preexposure Prophylaxis for HIV Infection among African Women. N Engl J Med 10.1056/NEJMoa1202614.
5. Kim C, Adams D, Bashirian S, Butera S, Folks T, et al. (2006) Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates. J Med Primatol 35: 210-216.
6. Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, et al. (2005) Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 19: 164-173.
7. García-Lerma JG, Otten RA, Qari SH, Jackson E, Cong M, et al. (2008) Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir PLoS Med. 5: e28.
8. García-Lerma JG, Cong M, Mitchell J, Youngpairoj AS, Zheng Q, et al. (2010) Intermittent prophylaxis with oral truvada protects macques form rectal SHIV infection. Sci Transl Med 2: 14ra14.
9. Haase AT, (2011) Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 62: 127-139.
10. Hu J, Gardner MB, Miller CJ, (2000) Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74: 6087-6095.
11. Ribeiro Dos Santos P, Rancez M, Prétet JL, Michel-Salzat A, Messent V, et al. (2011) Rapid dissemination of SIV follows multisite entry after rectal inoculation. PLoS One 6: e19493.
12. Wira CR, Fahey JV, (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22: 1909-1917.
13. Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, et al. (2011) Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 3: 112re114.
14. Blakley GB, Beamer TW, Dukelow WR, (1981) Characteristics of the menstrual cycle in nonhuman primates. IV. Timed mating in Macaca nemestrina. Lab Anim 15: 351-353.
15. Sodora DL, Gettie A, Miller CJ, Marx PA (1998) Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses Suppl 1: S119-123.
16. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, et al. (2011) High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 57: 261-264.
17. Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, et al. (2000) Modified wick method using weck-cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. Journal of Acquired Immune Deficiency Syndromes 24: 297-309.
18. Kuklenyik Z, Martin A, Pau CP, Garcia-Lerma JG, Heneine W, et al. (2009) Effect of mobile phase pH and organic content on LC-MS analysis of nucleoside and nucleotide HIV reverse transcriptase inhibitors. J Chromatogr Sci 47: 365-372.
19. Durand-Gasselin L, Da Silva D, Benech H, Pruvost A, Grassi J, (2007) Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells. Antimicrob Agents Chemother 51: 2105-2111.
20. Kuklenyik Z, Martin A, Pau C, Holder A, Youngpairoj AS, et al. (2009) On-line coupling of anion exchange and ion pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. J Chromatogr B Analyt Technol Biomed Life Sci 877: 3659-3666.
21. Parikh U, Dobard C, Sharma S, Cong M, Jia H, et al. (2009) Complete protection from repeated vaginal SHIV exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J Virol 83: 10358-10365.
22. Subbarao S, RA Otten RA, Ramos A, Kim C, Jackson E, et al. (2006) Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis 194: 904-911.
23. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, et al. (1999) Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 179: 871-882.
24. Dumond JB, Yeh RF, Patterson KB, Corbett AH, Jung BH, et al. (2007) Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS 21: 1899-1907.
25. Steiner RA, Schiller HS, Illner P, Blandau R, Gale CC, (1977) Sex hormones correlated with sex skin swelling and rectal temperature during the menstrual cycle of the pigtail macaque (Macaca nemestrina). Lab Anim Sci 27: 217-221.
26. Mordenti J, (1986) Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 75: 1028-1040.
27. Hawkins T, Veikley W, St Claire RL 3rd, Guyer B, Clark N, et al (2005) Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens. J Acquir Immune Defic Syndr 39: 406-411.
28. Pruvost A, Negredo E, Benech H, Theodoro F, Puig J, et al. (2005) Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 49: 1907-1914.
29. Wang LH, Begley J, St Claire RL 3rd, Harris J, Wakeford C, et al (2004) Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection. AIDS Res Hum Retroviruses 20: 1173-1182.
30. García-Lerma JG, Aung W, Cong ME, Zheng Q, Youngpairoj AS, et al. (2011) Natural substrate concentrations can modulate the prophylactic erfficacy of nucleotide HIV reverse transcriptase inhibitors. J Virol 85: 6610-6617.
31. HIV Prevention Trial Network (2012) HPTN 067, The ADAPT Study: A Phase II, Randomized, Open-Label, Pharmacokinetic and Behavioral Study of the Use of Intermittent Oral Emtricitabine/Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis (PrEP) http://www.hptn.org/research_studies/hptn067.asp: HIV Prevention Trials Network (HPTN) and Family Health Health International (FHI).
32. Lackner AA, Lederman MM, Rodriguez B (2012) HIV Pathogenesis: The Host. Cold Spring Harb Perspect Med 2: a007005.
33. Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP (1998) Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retroviruses Suppl 1: S125-130.
34. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, et al. (1996) Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2: 1084-1089.
35. Abel K, Rourke T, Lu D, Bost K, McChesney MB, Miller CJ, (2004) Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis 190: 1697-1705.
36. Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12: 19-26.
37. Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R,et al. (1999) The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 60: 15-24.
38. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409.
39. Celum C, Baeten JM, (2012) Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis 25: 51-57.
40. Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, et al. (2012) Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS One 7: e33103.